Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
From an HTS hit, a series of potent and selective inhibitors of GSK3beta have been designed based on a Cdk2-homology model and with the help of several crystal structures of the compounds within Cdk2.